Background: Major liver resection is the only therapeutic option for patients with malignant liver tumors. However, extended hepatectomy often leads to postoperative liver failure, mainly due to insufficient amounts of the remnant liver. Recently, selective portal vein occlusion (PVO) has been introduced to increase the remnant liver volume. This novel surgical technique initiated a progressive development in liver surgery, resulting in a significant increment in potential candidates for curative liver resection. Summary: The theoretical basis for this great advancement is formed by an understanding of the mechanisms of PVO-induced liver regeneration, mainly obtained from animal studies. The aim of this review is to give a comprehensive overview of the relevant animal models of PVO and to discuss the main characteristics of triggered liver regeneration, including the induced hemodynamic, morphological and functional alterations as well as the underlying molecular mechanisms, which might be of interest in both the laboratory and the clinic. Key Messages: Although basic research revealed the main characteristics of PVO-triggered liver regeneration within the last decades, several important issues regarding the regenerative process remain uncertain. To answer these open questions, additional well-designed animal experiments are needed in the future, which allow further refinement of this surgical technique.

Keywords:
Animal models, Liver regeneration, Liver surgery, Portal vein embolization, Portal vein ligation
1.
Clavien PA, Petrowsky H, DeOliveira ML, Graf R: Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-1559.
2.
von Frerichs FT, Murchison C: A Clinical Treatise on Diseases of the Liver. New York, Wood and Co, 1879.
3.
van Gulik TM, van den Esschert JW: James Cantlie's early messages for hepatic surgeons: how the concept of pre-operative portal vein occlusion was defined. HPB (Oxford) 2010;12:81-83.
4.
Makuuchi M, Takayasu K, Takuma T: Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma. J Jpn Soc Clin Surg 1984;45:14-20.
5.
Rous P, Larimore LD: Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-632.
6.
Sugimoto T, Yamada T, Iwata H, Sekino T, Matsumoto S, Ishida N, Manabe H, Kimura M, Takemura H: Two-stage portal vein ligation facilitates liver regeneration in rats. Eur Surg Res 2009;42:181-188.
7.
Liska V, Treska V, Mirka H, Kobr J, Sykora R, Skalicky T, Sutnar A, Bruha J, Fiala O, Vycital O, Chlumska A, Holubec L, Matejovic M: Interleukin-6 augments activation of liver regeneration in porcine model of partial portal vein ligation. Anticancer Res 2009;29:2371-2377.
8.
Liska V, Slowik P, Eggenhofer E, Treska V, Renner P, Popp FC, Mirka H, Kobr J, Sykora R, Schlitt HJ, Holubec L, Chlumska A, Skalicky T, Matejovic M, Dahlke MH: Intraportal injection of porcine multipotent mesenchymal stromal cells augments liver regeneration after portal vein embolization. In Vivo 2009;23:229-235.
9.
Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC: Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008;247:825-834.
10.
Ishikawa M, Yogita S, Iuchi M, Yagi K, Chikaishi H, Fukuda Y, Miyake H, Harada M, Tashiro S: Experimental and clinical studies on liver regeneration following transcatheter portal embolization. Hepatogastroenterology 2000;47:226-233.
11.
Huang JY, Yang WZ, Li JJ, Jiang N, Zheng QB: Portal vein embolization induces compensatory hypertrophy of remnant liver. World J Gastroenterol 2006;12:408-414.
12.
Tsoumakidou G, Theocharis S, Ptohis N, Alexopoulou E, Mantziaras G, Kelekis N, Brountzos E: Liver hypertrophy after percutaneous portal vein embolization: comparison of N-butyl-2-cyanocrylate versus sodium acrylate-vinyl alcohol copolymer particles in a swine model. Cardiovasc Intervent Radiol 2011;34:1042-1049.
13.
Lainas P, Boudechiche L, Osorio A, Coulomb A, Weber A, Pariente D, Franco D, Dagher I: Liver regeneration and recanalization time course following reversible portal vein embolization. J Hepatol 2008;49:354-362.
14.
van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM: Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013;36:25-34.
15.
de Graaf W, van den Esschert JW, van Lienden KP, Roelofs JJ, van Gulik TM: A rabbit model for selective portal vein embolization. J Surg Res 2011;171:486-494.
16.
Bretagnol F, Maggiori L, Zappa M, Sibert A, Vilgrain V, Panis Y: Selective portal vein embolization and colorectal liver metastases in rat: a new experimental model for tumor growth study. J Surg Res 2011;171:669-674.
17.
Ogasawara K, Uchino J, Une Y, Fujioka Y: Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible. Hepatology 1996;23:338-345.
18.
Rocheleau B, Ethier C, Houle R, Huet PM, Bilodeau M: Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 1999;277:G1000-G1007.
19.
Um SH, Nishida O, Tokubayashi M, Kimura F, Takimoto Y, Yoshioka H, Inque R, Kita T: Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Hepatology 1994;19:202-209.
20.
Duncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP: Embolization of portal vein branches induces hepatocyte replication in swine: a potential step in hepatic gene therapy. Radiology 1999;210:467-477.
21.
Schoen JM, Wang HH, Minuk GY, Lautt WW: Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 2001;5:453-464.
22.
Kollmar O, Corsten M, Scheuer C, Vollmar B, Schilling MK, Menger MD: Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue. Am J Physiol Gastrointest Liver Physiol 2007;292:G1534-G1542.
23.
Gock M, Eipel C, Linnebacher M, Klar E, Vollmar B: Impact of portal branch ligation on tissue regeneration, microcirculatory response and microarchitecture in portal blood-deprived and undeprived liver tissue. Microvasc Res 2011;81:274-280.
24.
Yokoyama Y, Wawrzyniak A, Sarmadi AM, Baveja R, Gruber HE, Clemens MG, Zhang JX: Hepatic arterial flow becomes the primary supply of sinusoids following partial portal vein ligation in rats. J Gastroenterol Hepatol 2006;21:1567-1574.
25.
Lautt WW: Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. Fed Proc 1983;42:1662-1666.
26.
Weinbren K: The portal blood supply and regeneration of the rat liver. Br J Exp Pathol 1955;36:583-591.
27.
Bax HR, Mansens BJ, Schalm L: Atrophy of the liver after occlusion of the bile ducts or portal vein and compensatory hypertrophy of the unoccluded portion and its clinical importance. Gastroenterology 1956;31:131-155.
28.
Kraus GE, Beltran A: Effect of induced infarction on rat liver implanted with walker carcinoma 256. Arch Surg 1959;79:769-774.
29.
Steiner PE, Martinez JB: Effects on the rat liver of bile duct, portal vein and hepatic artery ligations. Am J Pathol 1961;39:257-289.
30.
Rozga J, Jeppsson B, Bengmark S: Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol 1986;125:300-308.
31.
Bilodeau M, Aubry MC, Houle R, Burnes PN, Ethier C: Evaluation of hepatocyte injury following partial ligation of the left portal vein. J Hepatol 1999;30:29-37.
32.
Kerr JF: A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes. J Pathol Bacteriol 1965;90:419-435.
33.
Kerr JF: Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971;105:13-20.
34.
Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
35.
Ikeda K, Kinoshita H, Hirohashi K, Kubo S, Kaneda K: The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch Histol Cytol 1995;58:171-184.
36.
Kameoka N, Chijiiwa K, Kozaki N, Makino I, Naito T, Tanaka M: Hepatic adenine nucleotides and DNA synthesis during the regenerative and atrophic process of the liver lobes after selective portal vein ligation. Eur Surg Res 1996;28:212-221.
37.
Fulop A, Szijarto A, Harsanyi L, Budai A, Pekli D, Korsos D, Horvath I, Kovacs N, Karlinger K, Mathe D, Szigeti K: Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One 2014;9:e90760.
38.
Shimizu Y, Suzuki H, Nimura Y, Onoue S, Nagino M, Tanaka M, Ozawa T: Elevated mitochondrial gene expression during rat liver regeneration after portal vein ligation. Hepatology 1995;22:1222-1229.
39.
Yang WJ, Zhang QY, Yu ZP, Song QT, Liang HP, Xu X, Zhu GB, Jiang FZ, Shi HQ: Effects of nuclear factor-kappaB on rat hepatocyte regeneration and apoptosis after 70% portal branch ligation. World J Gastroenterol 2005;11:6775-6779.
40.
Tanaka H, Ikeda K, Matsuyama M, Kubo S, Hirohashi K, Kinoshita H: Morphological and functional changes after portal vein occlusion in rats. J Hepatobiliary Pancreat Surg 1997;4:365-372.
41.
Yamasaki M, Ikeda K, Nakatani K, Yamamoto T, Kawai Y, Hirohashi K, Kinoshita H, Kaneda K: Phenotypical and morphological alterations to rat sinusoidal endothelial cells in arterialized livers after portal branch ligation. Arch Histol Cytol 1999;62:401-411.
42.
Picard C, Starkel P, Sempoux C, Saliez A, Lebrun V, Horsmans Y: Molecular mechanisms of apoptosis in the liver of rats after portal branch ligation with and without retrorsine. Lab Invest 2004;84:618-628.
43.
Goto A: Regeneration of the experimental cirrhotic liver in rats. Nihon Gekagakkai Zasshi (Arch Jpn Chir) 1958;29:1622.
44.
Picard C, Lambotte L, Starkel P, Sempoux C, Saliez A, Van Den Berge V, de Saeger C, Horsmans Y: Retrorsine: a kinetic study of its influence on rat liver regeneration in the portal branch ligation model. J Hepatol 2003;39:99-105.
45.
Takeuchi E, Nimura Y, Mizuno S, Nagino M, Shoji-Kawaguchi M, Izuta S, Yoshida S: Ligation of portal vein branch induces DNA polymerases alpha, delta, and epsilon in nonligated lobes. J Surg Res 1996;65:15-24.
46.
Lambotte L, Li B, Leclercq I, Sempoux C, Saliez A, Horsmans Y: The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes. J Hepatol 2000;32:940-945.
47.
Kim RD, Kim JS, Watanabe G, Mohuczy D, Behrns KE: Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol 2008;25:92-103.
48.
Higgins GM, Anderson RM: Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931;12:186-202.
49.
Heinrich S, Jochum W, Graf R, Clavien PA: Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice. J Hepatol 2006;45:35-42.
50.
Fausto N, Riehle KJ: Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg 2005;12:181-189.
51.
Takamura K, Tsuchida K, Miyake H, Tashiro S, Sugino H: Activin and activin receptor expression changes in liver regeneration in rat. J Surg Res 2005;126:3-11.
52.
Abshagen K, Eipel C, Vollmar B: A critical appraisal of the hemodynamic signal driving liver regeneration. Langenbecks Arch Surg 2012;397:579-590.
53.
Sato Y, Koyama S, Tsukada K, Hatakeyama K: Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy. Surg Today 1997;27:518-526.
54.
Mueller L, Broering DC, Meyer J, Vashist Y, Goettsche J, Wilms C, Rogiers X: The induction of the immediate-early-genes Egr-1, PAI-1 and PRL-1 during liver regeneration in surgical models is related to increased portal flow. J Hepatol 2002;37:606-612.
55.
Morsiani E, Aleotti A, Ricci D: Haemodynamic and ultrastructural observations on the rat liver after two-thirds partial hepatectomy. J Anat 1998;192:507-515.
56.
Mortensen KE, Conley LN, Nygaard I, Sorenesen P, Mortensen E, Bendixen C, Revhaug A: Increased sinusoidal flow is not the primary stimulus to liver regeneration. Comp Hepatol 2010;9:2.
57.
Adibi S, Paschkis K, Cantarow A: Stimulation of the liver mitosis by blood serum from hepatectomized rats. Exper Cell Res 1959;18:396-398.
58.
Stärkel P, Horsmans Y, Sempoux C, De Saeger C, Wary J, Lause P, Maiter D, Lambotte L: After portal branch ligation in rat, nuclear factor kappaB, interleukin-6, signal transducers and activators of transcription 3, c-fos, c-myc, and c-jun are similarly induced in the ligated and nonligated lobes. Hepatology 1999;29:1463-1470.
59.
Stärkel P, Lambotte L, Sempoux C, De Saeger C, Saliez A, Maiter D, Horsmans Y: After portal branch ligation in the rat, cellular proliferation is associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2. Gut 2001;49:119-130.
60.
Ueda J, Chijiiwa K, Nakano K: Cyclin expression in the atrophying and proliferating lobes of the liver after portal vein branch ligation and hepatectomy in rats. J Surg Res 2004;120:89-96.
61.
Capussotti L, Muratore A, Baracchi F, Lelong B, Ferrero A, Regge D, Delpero JR: Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases. Arch Surg 2008;143:978-982; discussion 982.
62.
Broering DC, Hillert C, Krupski G, Fischer L, Mueller L, Achilles EG, Schulte am Esch J, Rogiers X: Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 2002;6:905-913; discussion 913.
63.
Furrer K, Tian Y, Pfammatter T, Jochum W, El-Badry AM, Graf R, Clavien PA: Selective portal vein embolization and ligation trigger different regenerative responses in the rat liver. Hepatology 2008;47:1615-1623.
64.
van den Esschert JW, van Lienden KP, de Graaf W, Maas MA, Roelofs JJ, Heger M, van Gulik TM: Portal vein embolization induces more liver regeneration than portal vein ligation in a standardized rabbit model. Surgery 2011;149:378-385.
65.
Kito Y, Nagino M, Nimura Y: Doppler sonography of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization. AJR Am J Roentgenol 2001;176:909-912.
66.
Bennink RJ, Tulchinsky M, de Graaf W, Kadry Z, van Gulik TM: Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 2012;42:124-137.
67.
van den Esschert JW, van Lienden KP, Alles LK, van Wijk AC, Heger M, Roelofs JJ, van Gulik TM: Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model. Ann Surg 2012;255:311-318.
68.
Hashimoto M, Watanabe G: Changes in functional capacity after portal branch ligation in rats. Surg Today 2001;31:1065-1069.
69.
Izuishi K, Wakabayashi H, Kokudo Y, Maeba T, Ryu M, Maeta H: Microsomal cytochrome p-450 monooxygenase system and its drug-metabolizing activity after partial portal vein ligation in the rat. World J Surg 1999;23:6-11.
70.
Takemura S, Minamiyama Y, Hirohashi K, Kubo S, Funae Y, Kinoshita H: Recovery of hepatic function determined by cytochrome p450-dependent drug metabolism lags after compensatory hepatic volume changes after portal vein ligation in rats. J Surg Res 2006;134:285-291.
71.
Katoh T, Tanaka M, Nimura Y, Kanai M, Nagino M, Ozawa T: Enhancement of rat liver mitochondrial function by portal branch ligation secures subsequent extended hepatectomy. Biochem Int 1991;24:107-116.
72.
Kucuktulu U, Alhan E, Tekelioglu Y, Ozekin A: The effects of pentoxifylline on liver regeneration after portal vein ligation in rats. Liver Int 2007;27:274-279.
73.
Urayama M, Ishiyama S, Kuzumaki T, Ishikawa K, Fuse A, Kuzu H, Igarashi Y, Suto K, Tsukamoto M: Change of liver function in hypertrophying lobe of rabbit liver after portal branch ligation. J Surg Res 1999;86:55-61.
74.
Mueller L, Grotelueschen R, Meyer J, Vashist YK, Abdulgawad A, Wilms C, Hillert C, Rogiers X, Broering DC: Sustained function in atrophying liver tissue after portal branch ligation in the rat. J Surg Res 2003;114:146-155.
75.
Uesaka K, Nimura Y, Nagino M: Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996;223:77-83.
76.
Hirai I, Kimura W, Fuse A, Suto K, Urayama M: Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003;133:495-506.
77.
Nishiyama Y, Yamamoto Y, Hino I, Satoh K, Wakabayashi H, Ohkawa M: 99mTc galactosyl human serum albumin liver dynamic SPET for pre-operative assessment of hepatectomy in relation to percutaneous transhepatic portal embolization. Nucl Med Commun 2003;24:809-817.
78.
Yumoto Y, Yagi T, Sato S, Nouso K, Kobayashi Y, Ohmoto M, Yumoto E, Nagaya I, Nakatsukasa H: Preoperative estimation of remnant hepatic function using fusion images obtained by (99m)Tc-labelled galactosyl-human serum albumin liver scintigraphy and computed tomography. Br J Surg 2010;97:934-944.
79.
de Graaf W, van Lienden KP, van den Esschert JW, Bennink RJ, van Gulik TM: Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 2011;98:825-834.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.